AzTrials
AzTrials

Brain Function7T-ATHENANCT06826287

7T Anatomo-functional Characterization of Structures in the Action Observation Network

An observational study of Brain Function and Cerebral Palsy, run by IRCCS Fondazione Stella Maris at 2 sites in Italy.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this study is to explore the anatomical-functional characteristics of the AON circuit (with particular interest for subcortical areas and the cerebellum), and the cortico-subcortical connectivity of the nodes of the AON circuit, using an ultra-high field (7T), high spatial resolution Magnetic Resonance… Read more about this study

Who is it for?
Ages 11 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Brain Function, Cerebral Palsy
What is being tested?
7T MR exam and clinical assessment
How many people
40 participants
Where
2 sitesItaly
Study dates
2 Dec 2024to 9 Aug 2025
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 11 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Study population: primary care clinic for CP; community sample for HC.

Who may be able to join

  • Patients with pre-, peri- or post-natal brain injury, documented by a previous MRI examination of the brain;
  • Intellectual development within the norm or within the mild deficit area, to guarantee understanding and cooperation in the 7T fMRI study;
  • Understanding of the Italian language;
  • Absence of known neurological and psychiatric pathologies;
  • Understanding of the Italian language;

Who cannot join

  • Contraindications to performing the 7T fMRI exam;
  • Neuropsychiatric comorbidity that precludes collaboration in the 7T fMRI study;
  • Lack of capacity to understand and to will;
  • Pregnancy;
  • For Healthy Controls
  • Contraindications to performing the 7T fMRI exam;
Show all 9Show fewer
  • Neuropsychiatric comorbidity that precludes collaboration in the 7T fMRI study;
  • Lack of capacity to understand and to will;
  • Pregnancy;

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Laura Biagi, PhD contact

+39050886175

laura.biagi@fsm.unipi.it

Giuseppina Sgandurra, MD contact

+39050886336

giuseppina.sgandurra@fsm.unipi.it

Italy2 sites, 1 recruiting
  • Fondazione IMAGO7

    Calambrone, PISA, 56018

    Active, not recruiting
  • IRCCS Fondazione Stella Maris

    Calambrone, Pisa, 56018

    Laura Biagi, PhD, +39050886175, laura.biagi@fsm.unipi.it

    Giuseppina Sgandurra, MD, +39050886336, giuseppina.sgandurra@fsm.unipi.it

    Recruiting

Other trials in Italy

About this study

Official title: More Than Cerebral Cortex: 7T Anatomo-functional Characterization of Cortical, Subcortical, and Cerebellar Structures Involved in THE Network of Action Observation

The goal of this study is to explore the anatomical-functional characteristics of the AON circuit (with particular interest for subcortical areas and the cerebellum), and the cortico-subcortical connectivity of the nodes of the AON circuit, using an ultra-high field (7T), high spatial resolution Magnetic Resonance Imaging protocol.

The main questions it aims to answer are:

Read more
  • Can we demonstrate the involvement of subcortical areas and cerebellum in the AON circuit in each single-subject?
  • Can we obtain similar results in a small group of patients with Cerebral Palsy (CP), in order to demonstrate the feasibility of this approach for the study of the mechanisms of AON reorganization, after early brain damage?
  • Are different patterns of functional activation correlated to different clinical characteristics of CP patients?

Participants will perform a 7 Tesla MRI scan, with a functional and anatomical dedicated protocol and will have a comprehensive clinical assessment before the MRI exam.

Read the detailed description

In healthy humans, brain functional representation of actions, either executed or observed, relies on the human action observation network (AON). Several studies demonstrated that AON activation is crucial for action understanding and for subserving imitation by observation of new motor skills. The demonstration of the activation of this circuit in patients with motor disorders have opened the way to new rehabilitation protocols based on the observation of meaningful actions followed by their execution (Observation to Imitate), often referred as Action Observation Therapy (AOT). In the last decade, AOT was widely used in adult stroke patients as well as in children with cerebral palsy (CP). Overall, these studies demonstrate a significant motor improvement after therapy, that is maintained at follow-up.

Functional Magnetic Resonance Imaging (fMRI) studies on the effects of AOT found a positive correlation between the functional improvements of manual abilities of these patients and the enlargement of movement-related brain regions, suggesting that AOT can promote the activation of mechanisms of brain plasticity and functional reorganization of the cortical areas responsible for movements. Recently, fMRI studies have demonstrated that also other brain regions, such as the cerebellum, the thalamus and the basal ganglia, belong to the AON.

Despite numerous studies on AON, the fine-grained details of this complex network, especially at subcortical level, and the reciprocal interactions between different brain regions are largely unknown. Moreover, no studies are available at submillimeter level concerning the involvement of subcortical structures. Compared with lower magnetic field systems, Ultra-High Field Magnetic Resonance (UHF-MR) permits a remarkable gain in terms of signal to noise ratio (SNR). This significant increase in SNR produces a great improvement of all imaging parameters, and can be exploited increasing spatial and/or temporal resolution. Moreover, at 7T, we assist also to an empowered sensitivity of the signal to modifications of the composition of tissue that can be translated in new or improved contrasts, such as susceptibility-weighted imaging.

fMRI technique is an advanced MR method that benefits from the use of UHF thanks to the positive combination of increased SNR and increased sensitivity to the effect generating the contrast (BOLD effect).

It has been demonstrated that an increase in the spatial resolution of UHF fMRI allows to describe the functional architecture of the cerebral cortex at mesoscopic (sub-millimeter) scale, hence revealing cortical columns-laminar fMRI profiles, and to segment subcortical structures, to explore their functional selectivity to external stimuli and topographic organization, and to study the cortex. Moreover, the increase in the sensitivity of fMRI at 7T allows to obtain statistically significant functional maps of brain activation not only in groups of subjects but also in individual subjects and individual events, opening new perspectives in the use of fMRI for clinical purposes.

The present study aims to use 7T fMRI to understand the mechanisms of the functional organization of the AON circuit, and in particular the relationship between the cerebral cortex and other structures such as the subcortical nuclei and the cerebellum, and to explore how this organization changes in the presence of lesions acquired at an early age, such as in patients with brain lesions that arose in the pre- or perinatal period, like Cerebral Palsy (CP).

We intend to enroll 28 healthy human subjects and 12 adolescents or young adults with CP. All participants will perform a 7 Tesla MRI scan, with a functional and anatomical dedicated protocol and CP patients will have a comprehensive clinical assessment before the MRI exam.

The MR protocol includes 3D MR sequences with very high spatial resolution. In particular, T1-weighted sequences with isotropic voxel size of 0.8mm is used in order to highlight and segment small substructures, but at the same time evaluating the compliance of subjects, especially of patients, in maintaining the position for long acquisition, without introducing motion artifacts. Analogously, 3D FLAIR sequences are acquired for a detailed study of lesions in CP patients.

fMRI acquisitions in humans are carried out by using Gradient-Echo Echo-Planar Imaging (GRE-EPI) sequences with spatial resolutions depending on the target of each functional series and by using imaging acceleration techniques as SENSE and multi-band approaches. For the study of functional connectivity and the whole AON circuit, comprehensive of the cerebellum, we will privilege whole brain coverage and relatively short temporal resolution (1-1.5 seconds), with a spatial resolution of 1.5mm isotropic voxel. On the other hand, for small substructures and laminar column studies, we will optimize an fMRI acquisition with isotropic voxel size of 0.7-0.9mm.

As functional task we use paradigms already described in previous studies and adapted for the 7T scanner.

Visual stimuli are presented in binocular vision by means of Liquid Cristal Display (LCD) goggles (VisuaStim-SVGA-Resonance Technology, USA). Participants observe short video-clips (lasting 4 s each), showing unimanual or bimanual actions performed by an actor, from a subjective perspective. The observed actions consist in grasping and using different tools (e.g., hammering, using a screwdriver, opening a jar etc.) or, as control condition, observation of the static initial frame of each clip. The objects are of different colors in order to avoid visual adaptation. The visual characteristics of each video are balanced between the experimental conditions to control the effects of brightness, contrast, sharpness and amount of visual information. During the rest period, in the absence of experimental stimuli, the participant have to fixate a white cross on a black background. During the entire fMRI acquisition, subject's performance are visually checked by the experimenter and kinematic parameters are recorded by using MR-compatible cameras.

Being tested
7T MR exam, clinical assessment
Keywords
magnetic resonance imaging, ultra high field, action observation network, cerebral palsy, functional re-organization, neural plasticity
Medical subject headings
Cerebral Palsy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 7T MR examOther

    a 7 Tesla MRI scan, with a functional and anatomical dedicated protocol

  • clinical assessmentOther

    A comprehensive clinical assessment before the MRI exam.

Study groups in NCT06826287
Study groupRoleWhat they receive
Healthy ControlsSubject without any known neurological and psychiatric pathologies
Receives: Other: 7T MR exam
CP patientsPatients with pre-, peri- or post-natal brain injury, as documented in a previous brain MRI examination
Receives: Other: 7T MR exam; Other: clinical assessment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. 7T activation maps of the AON

    volume (in cubic millimeters), coordinates (in millimeters), and percentage of signal change of the cortical, subcortical and cerebellar areas elicited by the observation of goal-directed actions

    Measured: Day 0

  2. 7T connectivity maps of the AON

    correlation between each pair of the cortical, subcortical and cerebellar areas elicited by the observation of goal-directed actions

    Measured: Day 0

Secondary outcomes (2)
  1. reproducibility

    percentage of healthy subjects in which it is possible to identify the AON circuit

    Measured: Day 0

  2. clinical correlation

    correlation between characteristics of activations (described as primary outcomes) and clinical assessment

    Measured: Day 0

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Feb 2025
  2. Study start2 Dec 2024
  3. Primary completion9 Aug 2025 (estimated)
  4. Study completion9 Aug 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06826287
Sponsor's protocol ID
7T-ATHENA
Acronym
7T-ATHENA
Status last verified
Feb 2025
First submitted
22 Jan 2025
Last updated
13 Feb 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: To be decided, verifying the compliance with European General Data Protection Regulation (GDPR) law

Questions about this trial

What is this clinical trial studying?

An observational study of Brain Function and Cerebral Palsy, run by IRCCS Fondazione Stella Maris at 2 sites in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 13 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Laura Biagi, PhD (+39050886175, laura.biagi@fsm.unipi.it), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

7T activation maps of the AON (time frame: Day 0). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Feb 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in